z-logo
open-access-imgOpen Access
Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load
Author(s) -
Alejandro GonzálezSerna,
Arie C. Glas,
Chanson J. Brumme,
Art F. Y. Poon,
Adriaóhpal De La Rosa,
Tania Mudrikova,
Viviane D. Lima,
Annemarie M. J. Wensing,
Richard Harrigan
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw455
Subject(s) - viral load , regimen , human immunodeficiency virus (hiv) , antiretroviral therapy , medicine , genotype , immunology , biology , virology , genetics , gene
HIV drug resistance, measured by the genotypic susceptibility score (GSS), has a deleterious effect on the virological outcome of HIV-1-infected patients. However, it is not known if GSS retains any predictive value for CD4 recovery in patients with suppressed viral load.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom